Company: ARMP
Filing Date: 2025-12-01
Form Type: 424B5
Source: 0001104659-25-117382
Chunk: 58

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-12-01
Form: 424B5
Chunk 58
---
licable prospectus supplements related to the particular series of warrants that we may offer under this prospectus, as well as any
related free writing prospectuses, and the complete warrant agreements and warrant certificates that contain the terms of the warrants.

General

We will describe in the applicable
prospectus supplement the terms of the series of warrants being offered, including:

| · | the offering price and aggregate number of warrants 
 offered;                                            |

| · | the currency for which the warrants may be purchased; |

| · | if applicable, the number of warrants issued                                                           
 with each share of common stock or preferred stock, or with the principal amount of any debt security; |

| · | if applicable, the date on and after which the                   
 warrants and the related shares will be separately transferable; |

| · | the number of shares of common stock or preferred                                                                           
 stock purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise; |

| · | the effect of any merger, consolidation, sale                                    
 or other disposition of our business on the warrant agreements and the warrants; |

| · | the terms of any rights to redeem or call the 
 warrants;                                     |

| · | any provisions for changes to or adjustments                                      
 in the exercise price or number of shares issuable upon exercise of the warrants; |

| · | the dates on which the right to exercise the 
 warrants will commence and expire;           |

| · | the manner in which the warrant agreements and 
 warrants may be modified; and                  |

| · | any other specific terms, preferences, rights      
 or limitations of or restrictions on the warrants. |

Before exercising their warrants,
holders of warrants will not have any of the rights of holders of common stock or preferred stock purchasable upon such exercise, including
the right to receive dividends, if any, or payments upon our liquidation, dissolution or winding up, or to exercise voting rights.

Exercise of Warrants

Each warrant will entitle
the holder to purchase the number of shares of common stock or preferred stock that we specify in the applicable prospectus supplement
at the exercise price that we describe in the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus
supplement, holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set
forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.

H